HDAC4 and Intellectual disability: Five individuals sharing similar clinical features including developmental delay, hypotonia and intellectual disability were all identified to carry de novo heterozygous missense substitutions in HDAC4 14–3-3 binding sites predicted to result in its nuclear translocation [37].